Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
Mais filtros











Base de dados
Intervalo de ano de publicação
1.
Int J Infect Dis ; 123: 176-179, 2022 Oct.
Artigo em Inglês | MEDLINE | ID: mdl-36057412

RESUMO

Disseminated toxoplasmosis associated with haemophagocytic lymphohistiocytosis (DT-HLH) is rare and difficult to diagnose compared to disseminated toxoplasmosis or HLH presenting alone. Because of the limited number of reported cases, the clinical characteristics and outcomes of DT-HLH are unknown. We report a case of DT-HLH in a human immunodeficiency virus (HIV)-infected patient who was successfully treated with early anti-toxoplasmic therapy and performed a comprehensive literature review. A 33-year-old Cameroonian woman was transferred to our hospital owing to HIV infection and encephalitis. Although she developed HLH, bone marrow biopsy did not reveal the cause. She was diagnosed as having DT-HLH via polymerase chain reaction testing of bone marrow biopsy tissue, blood, and cerebrospinal fluid. DT-HLH improved within the initial two weeks of treatment for toxoplasmosis (sulfamethoxazole-trimethoprim, trimethoprim 10 mg/kg/day and clindamycin 1,800 mg/day) before the introduction of antiretroviral therapy. To our knowledge, only eight cases of DT-HLH have been previously reported in the literature. Most patients died within three weeks of hospitalisation and were diagnosed by autopsy. Conversely, patients diagnosed antemortem were all treated and survived, including the currently reported patient. DT-HLH can lead to poor prognosis without early and proper treatment. Clinicians should consider toxoplasmosis in the differential diagnosis of HLH.


Assuntos
Infecções por HIV , Linfo-Histiocitose Hemofagocítica , Toxoplasmose , Adulto , Clindamicina/uso terapêutico , Feminino , HIV , Infecções por HIV/complicações , Humanos , Linfo-Histiocitose Hemofagocítica/complicações , Linfo-Histiocitose Hemofagocítica/diagnóstico , Linfo-Histiocitose Hemofagocítica/tratamento farmacológico , Sulfametoxazol/uso terapêutico , Toxoplasmose/complicações , Toxoplasmose/diagnóstico , Toxoplasmose/tratamento farmacológico , Trimetoprima/uso terapêutico
2.
J Infect Chemother ; 21(12): 873-6, 2015 Dec.
Artigo em Inglês | MEDLINE | ID: mdl-26386777

RESUMO

Streptococcal toxic shock syndrome (TSS) is a systemic illness usually caused in the setting of infection by group A Streptococcus (GAS). The primary infections are often invasive infections of the respiratory tract or necrotizing infections of the skin and soft tissue, but some infections occur without relevant focus. GAS vaginitis is a rare condition among adult women and is accordingly thought to be uncommon as a cause of streptococcal TSS. Here we report the cases of two postmenopausal women with streptococcal TSS secondary to GAS vaginitis, one aged 55 and one aged 60. Both came to our emergency department with complaints or symptoms of abdominal pain, fever, hypotension, and multi-organ failure. In both cases, the relevant factor associated with streptococcal infection was a recent episode of GAS vaginitis. Both underwent fluid management and 14 days of antibiotic treatment and fully recovered without complications. Vaginitis was likely to be the primary infectious trigger of TSS in these two cases. Intrauterine device insertion, endometrial biopsy, and post-partum state have all been previously reported in TSS patients, and the female genital tract has been described as a portal of entry. GAS vaginitis warrants appropriate treatment as it may progress to severe systemic infection as described.


Assuntos
Choque Séptico/diagnóstico , Choque Séptico/microbiologia , Infecções Estafilocócicas/diagnóstico , Streptococcus pyogenes/isolamento & purificação , Vaginose Bacteriana/diagnóstico , Feminino , Humanos , Infecções Intra-Abdominais/diagnóstico , Infecções Intra-Abdominais/tratamento farmacológico , Infecções Intra-Abdominais/microbiologia , Pessoa de Meia-Idade , Choque Séptico/tratamento farmacológico , Infecções Estafilocócicas/tratamento farmacológico , Streptococcus pyogenes/efeitos dos fármacos , Vaginose Bacteriana/tratamento farmacológico
3.
Infect Immun ; 80(4): 1437-44, 2012 Apr.
Artigo em Inglês | MEDLINE | ID: mdl-22290145

RESUMO

Interleukin 1 receptor antagonist (IL-1Ra)-deficient BALB/c mice develop spontaneous arthritis resembling human rheumatoid arthritis. We herein report that infection with Toxoplasma gondii, an intracellular protozoan, is capable of ameliorating the spontaneous development of arthritis in IL-1Ra-deficient mice. The onset of arthritis development was delayed and the severity score of arthritis was significantly suppressed in T. gondii-infected mice. Expression of IL-12p40 mRNA from CD11c(+) cells of mesenteric lymph nodes (mLN) and spleen markedly increased at 1 week after peroral infection. While CD11c(+) cells also produced IL-10, IL-1ß, and IL-6, CD4(+) T cells from T. gondii-infected mice expressed significantly high levels of T-bet and gamma interferon (IFN-γ) mRNA in both mLN and spleen. Levels of GATA-3/IL-4 mRNA or RORγt/IL-17 mRNA decreased in the infected mice, indicating Th1 cell polarization and the reduction of Th2 and Th17 cell polarization. The severity of arthritis was related to Th1 cell polarization accompanied by Th17 cell reduction, demonstrating the protective role of the T. gondii-derived Th1 response against Th17 cell-mediated arthritis in IL-1Ra-deficient mice.


Assuntos
Artrite/imunologia , Doenças Hereditárias Autoinflamatórias/imunologia , Células Th17/imunologia , Toxoplasma , Toxoplasmose/imunologia , Animais , Antígeno CD11c/biossíntese , Linfócitos T CD4-Positivos/imunologia , Fator de Transcrição GATA3/biossíntese , Fator de Transcrição GATA3/genética , Interferon gama/biossíntese , Proteína Antagonista do Receptor de Interleucina 1/imunologia , Interleucina-10/biossíntese , Subunidade p40 da Interleucina-12/biossíntese , Subunidade p40 da Interleucina-12/genética , Interleucina-17/biossíntese , Interleucina-17/genética , Interleucina-1beta/biossíntese , Interleucina-4/biossíntese , Interleucina-4/genética , Interleucina-6/biossíntese , Linfonodos/patologia , Camundongos , Camundongos Endogâmicos BALB C , Camundongos Knockout , Membro 3 do Grupo F da Subfamília 1 de Receptores Nucleares/biossíntese , Membro 3 do Grupo F da Subfamília 1 de Receptores Nucleares/genética , RNA Mensageiro/biossíntese , Baço/citologia , Células Th1/imunologia , Células Th2/imunologia , Toxoplasmose/metabolismo
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA